![Sanjay Chanda](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sanjay Chanda
Corporate Officer/Principal at
AN2 THERAPEUTICS, INC.
Net worth: 166 428 $ as of 29/06/2026
Profile
Dr. Sanjay Chanda is a Chief Development Officer at AN2 Therapeutics, Inc. and a Chief Development Officer at Cortene, Inc. Dr. Chanda was previously employed as a Co-Founder by Auration Biotech, Inc., a Senior Vice President-Drug Development by Anacor Pharmaceuticals LLC, and a Chief Development Officer by Tioma Therapeutics, Inc. He received his undergraduate degree from Birla Institute of Technology & Science, a graduate degree from Birla Institute of Technology & Science and a doctorate degree from Northeast Louisiana University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/03/2026 | 34,386 ( 0.1% ) | 166 428 $ | 29/06/2026 |
Sanjay Chanda active positions
| Companies | Position | Start |
|---|---|---|
| AN2 THERAPEUTICS, INC. | Corporate Officer/Principal | 31/10/2019 |
Cortene, Inc.
 Cortene, Inc. BiotechnologyHealth Technology Develops therapeutics for treating a broad range of disorders related to the stress response | Corporate Officer/Principal | 31/01/2017 |
Former positions of Sanjay Chanda
| Companies | Position | End |
|---|---|---|
Arch Oncology, Inc.
 Arch Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company that develops biologic therapies for treatment of patients with tumors and hematologic malignancies | Corporate Officer/Principal | 31/07/2017 |
| ANACOR PHARMACEUTICALS INC | Corporate Officer/Principal | 30/09/2016 |
Auration Biotech, Inc.
 Auration Biotech, Inc. BiotechnologyHealth Technology Develops novel therapeutics for treatment of diseases of ear, nose and throat | Founder | - |
Training of Sanjay Chanda
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
26
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Birla Institute of Technology & Science
 Birla Institute of Technology & Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anacor Pharmaceuticals LLC
 Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a bio pharmaceutical company | Health Technology |
Northeast Louisiana University
 Northeast Louisiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arch Oncology, Inc.
Arch Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company that develops biologic therapies for treatment of patients with tumors and hematologic malignancies | Health Technology |
Auration Biotech, Inc.
Auration Biotech, Inc. BiotechnologyHealth Technology Develops novel therapeutics for treatment of diseases of ear, nose and throat | Health Technology |
AN2 Therapeutics, Inc.
 AN2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics | Health Technology |
Cortene, Inc.
Cortene, Inc. BiotechnologyHealth Technology Develops therapeutics for treating a broad range of disorders related to the stress response | Health Technology |
- Stock Market
- Insiders
- Sanjay Chanda
Choose MarketScreener 
